Molecular and Cellular Pediatrics is indexed in PubMed Central
The German Society of Pediatrics and Adolescent Medicine (DGKJ) are providing financial support to aid any authors who require assistance with the article-processing charge (1690 EUR/ 1390 GBP/ 2090 USD). If you do not have access to a funding source, please request DGKJ sponsorship during the submission process, by entering the code RA-DGKJ-MACP-1118 on the payment page. The sponsorship will cover the full cost of the article-processing charge.
Aims and scope
Molecular and Cellular Pediatrics is an international and interdisciplinary open access journal publishing peer-reviewed articles on innovative research in pediatrics.
The focus and the topics of this journal cover research areas relevant to pediatrics including rare diseases, genetic diseases, gene therapy, cardiology, endocrinology, gastroenterology, genetics, immunology, infectiology, nephrology, neurology, oncology and hematology, pneumology, metabolism, neonatology and translational medicine in pediatrics.
Molecular and Cellular Pediatrics is dedicated to exchange and discussion of current molecular and cellular concepts in pediatrics. This includes frontline reviews on the latest developments, original research articles and a forum for discussion of pathophysiological concepts including therapeutic approaches.
Molecular and Cellular Pediatrics is an official journal of the German Society of Child and Adolescent Medicine (Deutsche Gesellschaft für Kinder- und Jugendmedizin e.V., DGKJ).
With regard to the peer-review process, the journal’s policy is in keeping with the “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals” (www.icmje.org/recommendations).
Molecular and Cellular Pediatrics follows the Committee of Publications Ethics (COPE) - Guidelines.
All Manuscripts submitted for publication presenting results from studies on probands or patients must comply with the Declaration of Helsinki according to the author guidelines for original papers.
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Molecular and Cellular Pediatrics is affiliated with the German Society of Pediatrics and Adolescent Medicine (DGKJ).
Annual Journal Metrics
56 days to first decision for reviewed manuscripts only
53 days to first decision for all manuscripts
105 days from submission to acceptance
22 days from acceptance to publication
24 Altmetric Mentions
- ISSN: 2194-7791 (electronic)